Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Multiple Myeloma 2Lymphoma 2Thyroid Neoplasms 1Spinal Cord Compression 1Parathyroid Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Kidney Neoplasms 1Hypercalcemia 1Humoral Hypercalcemia Of Malignancy 1Hodgkin Disease 1Head and Neck Neoplasms 1Endocrine Gland Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 7Nivolumab 3Drug Therapy 3Biopsy, Fine-Needle 3epacadostat 2Thiotepa 2Nonlinear Optical Microscopy 2Ipilimumab 2Gemcitabine 2Filgrastim 2Cytological Techniques 2Cyclophosphamide 2Blood Specimen Collection 2vocimagene amiretrorepvec 1tanespimycin 1spartalizumab 1motexafin gadolinium 1fludarabine 1entrectinib 1belinostat 1atezolizumab 1alectinib 1aldesleukin 1Valganciclovir 1Topotecan 1Tomography, Emission-Computed 1Tissue Banks 1Sirolimus 1SUB1 protein, human 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Denosumab × Lymphoid × Clear all
NCT00896454 2018-10-17

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Amgen

Phase 2 Completed
33 enrolled 22 charts
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cellThoracic

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Hypercalcemia, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Parathyroid Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡